Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Appoints Graham Phillips as Chief Operating Officer

See Release

All News

Archives

Endologix Announces 12-Month Results of DETOUR-2 Trial at 2022 VIVA Late-Breaking Clinical Trial Session

Endologix Reports Five-Year Data of the LEOPARD Trial at 2022 Vascular InterVentional Advances (VIVA) Conference

ELEVATE IDE Study highlights the Safety and Effectiveness of the ALTO® Abdominal Stent Graft System in One-year Results; Data to Be Presented at 2022 VEITHsymposium

Endologix Submits Premarket Approval (PMA) Application to FDA for the DETOUR™ System.

Endologix Receives CE Mark Certification under EU MDR for AFX®2 Endovascular AAA System